New Delhi [India], April 23 (ANI): Zydus Cadila received emergency use approval from the Drugs Controller General of India (DGCI) on Friday for the use of 'Virafin', Pegylated Interferon alpha-2b (PegIFN) in treating moderate COVID-19 infection in adults.
New Delhi [India], April 23 (ANI): The Drugs Controller General of India (DGCI) has approved emergency use for Zydus Cadila's Pegylated Interferon alpha-2b, 'Virafin' for treating moderate COVID-19 infection in adults.
Kochi (Kerala) [India], April 20 (ANI): R Venugopal, Nodal officer for Oxygen supply in Kerala and Deputy Chief Controller of Explosives of Petroleum and Explosives Safety Organisation (PESO), on Monday said that the state has no shortage of medical oxygen and is well equipped for any eve
Bengaluru (Karnataka) [India], April 14 (ANI): Private Hospitals and Nursing Homes Association's (PHANA) executive committee member Dr Rajashekar on Wednesday admitted that there was a shortage of Remdesivir doses for COVID-19 treatment and that the Drug Controller General of India (DGCI) ha
Hyderabad (Telangana) [India], April 13 (ANI): Dr Reddy's Laboratories said on Tuesday it has received permission from the Drug Controller General of India (DCGI) to import Sputnik vaccine into India for restricted use in emergency situations.
Washington [US], April 10 (ANI): A molecule called microRNA-29 as a powerful controller of brain maturation in mammals has been discovered by a team, led by scientists at the University of North Carolina (UNC) School of Medicine. Deleting microRNA-29 in mice caused problems very similar to t
Washington [US], April 7 (ANI): A team, led by scientists at the University of North Carolina (UNC) School of Medicine, have identified a molecule called microRNA-29 as a powerful controller of brain maturation in mammals. Deleting microRNA-29 in mice caused problems very similar to those se
New Delhi (India) [India], April 5 (ANI): Pharmaceutical Company Zydus Cadila on Monday informed that it has sought approval of the Drugs Controller General of India (DGCI) for using its hepatitis drug for the treatment of coronavirus.
New Delhi [India], March 10 (ANI): The Subject expert committee (SEC) of Drugs Controller General of India (DCGI) on Wednesday recommended removing the "clinical trial mode" condition related to Bharat Biotech's Covaxin.
Hyderabad (Telangana) [India], Feb 19 (ANI): Dr Reddy's Laboratories said on Friday it has initiated the process with the Drugs Controller General of India (DCGI) for emergency use authorisation of human adenoviral vector-based platform vaccine candidate Sputnik V.
Alwar (Rajasthan) [India], February 10 (ANI): Deputy Controller of Rajiv Gandhi General Hospital in Rajasthan's Alwar Sushil Batra on Wednesday informed that a few staff members were seen dancing in an empty ward during duty hours, in a viral video and investigations have begun in the matter
New Delhi [India] February 5 (ANI): The subject expert panel of Drugs Controller General of India did not recommend granting emergency use authorisation to Pfizer's COVID-19 vaccine noting that the firm has not proposed plans to generate safety and immunogenicity data concerning Indian popu